Palisade Bio, Inc.
PALI
$1.87
-$0.05-2.60%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 149.21% | 30.82% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 241.58% | 2.78% | |||
| Operating Income | -241.58% | -2.78% | |||
| Income Before Tax | -210.29% | -3.02% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -210.29% | -3.02% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -210.29% | -3.02% | |||
| EBIT | -241.58% | -2.78% | |||
| EBITDA | -241.70% | -2.78% | |||
| EPS Basic | 88.72% | 33.88% | |||
| Normalized Basic EPS | 88.70% | 33.88% | |||
| EPS Diluted | 88.72% | 33.88% | |||
| Normalized Diluted EPS | 88.70% | 33.88% | |||
| Average Basic Shares Outstanding | 2,650.55% | 55.80% | |||
| Average Diluted Shares Outstanding | 2,650.55% | 55.80% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||